Stem cell therapy aims to reboot the immune system and prevent MS attacks. Though it shows promise and is available through clinical trials, it’s not FDA-approved to treat MS. If you’re ...

20, 2024 – The FDA has approved remestemcel-L ... of donor bone marrow transplantation. The approval marks the first stem cell therapy for the condition and will be marketed under the brand ...

Three Georgia companies and their principals have been banned from continuing their "bogus claims" that their stem cell ...

Allogeneic stem cell therapy allows "off the shelf" cells ... Presuming that EU approval can be secured, the next major milestone will be FDA approval. In March this year the company received ...

HOUSTON, January 13, 2025--(BUSINESS WIRE)--IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs ... potential of pluripotent stem cell therapy. IPS HEART has also ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...

Ryoncil is the first FDA-approved mesenchymal stromal cell (MSC ... as a complication of allogeneic hematopoietic (blood) stem cell transplantation (allo-HSCT). In allo-HSCT, a patient receives ...